Best overall response and PFS for each CAR T-cell therapy product, stratified by prior ide-cel response. Over all response (A) and Kaplan-Meier curves (B) to ide-cel and cilta-cel based on the International Myeloma Working Group criteria. (C) Cilta-cel PFS stratified by prior ide-cel response duration <12 months and >12 months.